galacto-<wbr/>Dapagliflozin

galacto-Dapagliflozin

CAT N°: 15952
Price:

From 83.00 70.55

Renal glucose transport is mediated by sodium-glucose cotransporters (SGLT) 1 and 2.{20894} In humans, SGLT2 is responsible for the majority of glucose reabsorption in the kidney.{20894} galacto-Dapagliflozin is a potent inhibitor of human SGLT2 that is 1,000-fold less potent at human SGLT1 (Ki values are 2 and 25,000 nM, respectively).{20895} It also dissociates from hSGLT2 more slowly than from hSGLT1 (half-time off rates are 19 and 0.9 seconds, respectively).{20895}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-galactitol
  • Correlated keywords
    • biochemical inhibitor diabetes metabolic syndrome inhibit hSGLT2 human sodium/glucose cotransporter sodium glucose galactodapagliflozin g-DAPA gDAPA
  • Product Overview:
    Renal glucose transport is mediated by sodium-glucose cotransporters (SGLT) 1 and 2.{20894} In humans, SGLT2 is responsible for the majority of glucose reabsorption in the kidney.{20894} galacto-Dapagliflozin is a potent inhibitor of human SGLT2 that is 1,000-fold less potent at human SGLT1 (Ki values are 2 and 25,000 nM, respectively).{20895} It also dissociates from hSGLT2 more slowly than from hSGLT1 (half-time off rates are 19 and 0.9 seconds, respectively).{20895}

We also advise you